Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-031793

Chief Commercial Officer sold 25,000 shares at $21.18 ($529,420)

  • Chief Commercial Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Maduck Sean Chief Commercial Officer 2021-08-03 Option exercise +25,000 $3.29 $82,250 65,024 D: show line 1 in the form
Maduck Sean Chief Commercial Officer 2021-08-03 Sale −25,000 $21.18 $529,420 40,024 D: show line 2 in the form
Open-market sales · 25,000 sh · avg $21.18 · $529,420

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Maduck Sean Chief Commercial Officer 2021-08-03 Option exercise · Stock Option (Right to Buy) −25,000 172,602 D: show line 3 in the form
Loading xslF345X03/doc4.xml…